Verona Pharma (VRNA) Income Statement (2020 - 2025)
Income Statement report data from Mar 31, 2020 to Jun 30, 2025 for Verona Pharma (VRNA).
Reported currency: USD
| Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||
Total Revenue | 103M (+35.25%) | 76M (+108.02%) | 37M (+552.31%) | 5.62M | - | - | - | - | - | - | 460K | - | - | - | - | 40M | - | - | - | - | - | - |
Cost Of Revenue | - | 3.41M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Costof Goods And Services Sold | - | 3.41M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | 103M (+41.58%) | 73M (+98.72%) | 37M (+552.31%) | 5.62M | - | - | - | - | - | - | 460K | - | - | - | - | 40M | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||||
Research And Development | 13M (-7.83%) | 14M (+229.04%) | 4.27M (-59.53%) | 11M (-45.59%) | 19M (+213.75%) | 6.18M (+104.64%) | 3.02M (+2.03%) | 2.96M | -2.47M | 13M | -2.80M | 9.84M (+2.82%) | 9.57M (-41.36%) | 16M (-7.95%) | 18M (-0.45%) | 18M (+6.46%) | 17M (+45.48%) | 12M (-16.61%) | 14M (+31.58%) | 10M (+73.80%) | 6.03M (+1.52%) | 5.94M |
Selling General And Administrative | 72M (+4.37%) | 69M (+53.27%) | 45M (+28.10%) | 35M (-28.22%) | 49M (+140.04%) | 20M (+36.47%) | 15M (+12.13%) | 13M (+7.32%) | 12M (+29.72%) | 9.59M (+15.26%) | 8.32M (+57.28%) | 5.29M (-4.34%) | 5.53M (-25.67%) | 7.44M (+29.17%) | 5.76M (-47.06%) | 11M (+36.17%) | 7.99M (-13.90%) | 9.28M (-18.95%) | 11M (+38.29%) | 8.28M (+161.20%) | 3.17M (-53.79%) | 6.86M |
Operating Expenses | 90M (+8.01%) | 83M (+61.84%) | 51M (+11.02%) | 46M (-32.34%) | 68M (+157.12%) | 27M (+47.92%) | 18M (+10.30%) | 16M (+63.59%) | 9.97M (-55.09%) | 22M (+278.19%) | 5.87M (-61.20%) | 15M (+0.20%) | 15M (-36.45%) | 24M (+1.15%) | 23M (-18.12%) | 29M (+16.11%) | 25M (+18.86%) | 21M (-17.63%) | 25M (+34.47%) | 19M (+104.02%) | 9.20M (-28.13%) | 13M |
Operating Income | ||||||||||||||||||||||
Operating Income | 13M | -10.32M (-29.99%) | -14.74M (-63.76%) | -40.67M (-40.56%) | -68.42M (+157.12%) | -26.61M (+47.92%) | -17.99M (+10.30%) | -16.31M (+63.76%) | -9.96M (-55.14%) | -22.20M (+310.35%) | -5.41M (-64.24%) | -15.13M (+0.20%) | -15.10M (-36.45%) | -23.76M (+1.15%) | -23.49M | 11M | -24.71M (+18.86%) | -20.79M (-17.63%) | -25.24M (+34.47%) | -18.77M (+104.02%) | -9.20M (-28.13%) | -12.80M |
EBITDA | 14M | -10.02M (-30.80%) | -14.48M (-64.40%) | -40.67M (-40.32%) | -68.15M (+158.63%) | -26.35M (+48.20%) | -17.78M (+10.02%) | -16.16M (+64.73%) | -9.81M (-55.49%) | -22.04M (+319.01%) | -5.26M (-64.86%) | -14.97M (+0.27%) | -14.93M (-36.74%) | -23.60M (+1.16%) | -23.33M | 11M | -24.56M (+19.05%) | -20.63M (-17.78%) | -25.09M (+34.82%) | -18.61M (+105.86%) | -9.04M (-28.48%) | -12.64M |
Other Income / Expenses | ||||||||||||||||||||||
Interest Income | 4.30M (+10.54%) | 3.89M (-2.51%) | 3.99M (-16.00%) | 4.75M (+51.27%) | 3.14M (-7.10%) | 3.38M (+2.74%) | 3.29M (-2.95%) | 3.39M (-0.29%) | 3.40M (+26.87%) | 2.68M (+44.09%) | 1.86M (+138.46%) | 780K (+358.82%) | 170K (+750.00%) | 20K | - | - | - | - | 10K (0.00%) | 10K (-66.67%) | 30K (-57.14%) | 70K |
Interest Expense | -6.82M (-33.07%) | -10.19M (-1.26%) | -10.32M (+4.45%) | -9.88M (+461.36%) | -1.76M (+10.69%) | -1.59M (+156.45%) | -620.00K (+55.00%) | -400.00K (-45.95%) | -740.00K (+155.17%) | -290.00K (+26.09%) | -230.00K (+91.67%) | -120.00K (+33.33%) | -90.00K (+12.50%) | -80.00K (0.00%) | -80.00K (-11.11%) | -90.00K (+12.50%) | -80.00K (0.00%) | -80.00K (+100.00%) | -40.00K | - | - | - |
Net Interest Income | 11M (-21.08%) | 14M (-1.54%) | 14M (-2.19%) | 15M (+198.57%) | 4.90M (-1.21%) | 4.96M (+26.53%) | 3.92M (+3.43%) | 3.79M (-8.45%) | 4.14M (+39.39%) | 2.97M (+42.11%) | 2.09M (+132.22%) | 900K (+246.15%) | 260K (+160.00%) | 100K (+11.11%) | 90K (0.00%) | 90K (0.00%) | 90K (0.00%) | 90K (+125.00%) | 40K (+300.00%) | 10K (-66.67%) | 30K (-57.14%) | 70K |
Other Non Operating Income | 1.10M (+1733.33%) | 60K | -1.45M | 3.09M | -2.78M (+1163.64%) | -220.00K | 1.21M | -1.32M (+10.92%) | -1.19M | 3.25M (+47.73%) | 2.20M | -1.12M (-57.89%) | -2.66M (+189.13%) | -920.00K | 60K | -50.00K | 2.75M | -340.00K | 480K | -130.00K | 140K (-68.18%) | 440K |
Net Income | ||||||||||||||||||||||
Income Before Tax | 12M | -16.56M (-35.21%) | -25.56M (-40.15%) | -42.71M (-38.83%) | -69.82M (+178.83%) | -25.04M (+76.59%) | -14.18M (-3.14%) | -14.64M (+72.24%) | -8.50M (-48.70%) | -16.57M (+59.02%) | -10.42M (-33.12%) | -15.58M (-11.93%) | -17.69M (-28.53%) | -24.75M (+5.27%) | -23.51M | 11M | -22.04M (+3.91%) | -21.21M (-14.44%) | -24.79M (+31.23%) | -18.89M (+109.42%) | -9.02M (-26.61%) | -12.29M |
Income Tax Expense | -40.00K (-83.33%) | -240.00K | 8.27M (+3208.00%) | 250K (-75.25%) | 1.01M (+34.67%) | 750K | -50.00K | 40K (-87.10%) | 310K (+82.35%) | 170K (+466.67%) | 30K (-50.00%) | 60K (-25.00%) | 80K (0.00%) | 80K | -250.00K | 130K (+333.33%) | 30K (-62.50%) | 80K (+100.00%) | 40K (0.00%) | 40K (+100.00%) | 20K (-60.00%) | 50K |
Net Income From Continuing Operations | 12M | -16.32M (-51.76%) | -33.83M (-21.25%) | -42.96M (-39.35%) | -70.83M (+174.64%) | -25.79M (+82.52%) | -14.13M (-3.81%) | -14.69M (+66.74%) | -8.81M (-47.37%) | -16.74M (+60.19%) | -10.45M (-33.23%) | -15.65M (-11.93%) | -17.77M (-28.46%) | -24.84M (+6.79%) | -23.26M | 11M | -22.07M (+3.66%) | -21.29M (-14.22%) | -24.82M (+31.11%) | -18.93M (+109.40%) | -9.04M (-26.80%) | -12.35M |
Net Income | 12M | -16.32M (-51.76%) | -33.83M (-21.25%) | -42.96M (-39.35%) | -70.83M (+174.64%) | -25.79M (+82.52%) | -14.13M (-3.81%) | -14.69M (+66.74%) | -8.81M (-47.37%) | -16.74M (+60.19%) | -10.45M (-33.23%) | -15.65M (-11.93%) | -17.77M (-28.46%) | -24.84M (+6.79%) | -23.26M | 11M | -22.07M (+3.66%) | -21.29M (-14.22%) | -24.82M (+31.11%) | -18.93M (+109.40%) | -9.04M (-26.80%) | -12.35M |